tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Mccarthy, 175 are a BUY (83.73%), 30 are a HOLD (14.35%), 4 are a SELL (1.91%).
Analyst Jason Mccarthy works at MAXIM GROUP with a stock forecast success ratio of 34.29% fulfilled within 153.48 days on average.
Jason Mccarthy’s has documented 406 price targets and ratings displayed on 66 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MBRX, Moleculin Biotech at 26-Mar-2024.
Analyst best performing recommendations are on ANVS (ANNOVIS BIO ).
The best stock recommendation documented was for ANVS (ANNOVIS BIO ) at 5/13/2021. The price target of $45 was fulfilled within 8 days with a profit of $21.72 (93.3%) receiving and performance score of 116.62.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
6
$-1.52 (-20.21%)
5
1 years 5 months 8 days ago
2/3 (66.67%)
$1.85 (44.58%)
257
Buy
15
1 years 5 months 14 days ago
1/2 (50%)
$10.34 (221.89%)
61
Buy
2 years 4 months 24 days ago
0/1 (0%)
$332.5 (79.64%)
Buy
75
$70.79 (1681.47%)
50
3 years 5 months 11 days ago
2/3 (66.67%)
$45.92 (117.11%)
101
Buy
22
3 years 11 months 14 days ago
1/3 (33.33%)
$-59.25 (-72.92%)
820
Which stock is Jason Mccarthy is most bullish on?
Which stock is Jason Mccarthy is most reserved on?
What Year was the first public recommendation made by Jason Mccarthy?
